Obagi Medical Products, Inc. (NASDAQ: OMPI), a leader in topical aesthetic and therapeutic skin health systems, today reported financial results for the second quarter and six months ended June 30, ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin health systems, has been honored with two Beauty Choice Awards from ...

LONG BEACH, Calif.--(BUSINESS WIRE)--Obagi Medical Products, Inc. (Nasdaq:OMPI), a leader in topical aesthetic and therapeutic skin-health systems, announces the launch of Obagi Hydrate. This new ...

Read the original article on Purewow. The serum is made for all skin types and claims to offer antioxidant, anti-inflammatory and anti-aging benefits that leave complexions bright and glowy. Indeed, ...

Valeant Pharmaceuticals International is to acquire all of the outstanding common stock of Obagi Medical Products for $19.75 per share in cash, which represents a 28 percent premium to Obagi’s closing ...

Deal sits at $19.75 per share, a 28% premium to yesterday's close. Valeant, which specializes in products designed for dermatology, neurology, and branded generics, has signed a definitive agreement ...

The offer price represents a 28% premium to Obagi's closing share price on Mar 19, 2013. Valeant Pharma expects to close the transaction, which has been approved by Obagi’s board, in the first half of ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” or the “Company”), ...

Obagi Medical, a leading innovator in physician-dispensed skincare and aesthetic solutions and part of Waldencast plc (NASDAQ: WALD) (“Waldencast” ...

PureWow editors select every item that appears on this page, and some items may be gifted to us. Additionally, PureWow may earn compensation through affiliate links within the story. All prices are ...